These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38489662)

  • 81. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.
    Lee HH; Cho Y; Choi YJ; Huh BW; Lee BW; Kang ES; Park SW; Cha BS; Lee EJ; Lee YH; Huh KB
    Cardiovasc Diabetol; 2020 Jun; 19(1):81. PubMed ID: 32534588
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
    Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients.
    Tarantino G; Citro V; Balsano C; Capone D
    Front Med (Lausanne); 2021; 8():634962. PubMed ID: 34095164
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
    Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
    Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities.
    Tarantino G; Finelli C; Gioa S; Citro V; La Sala N; Gentile M
    Scand J Clin Lab Invest; 2016 Nov; 76(7):544-552. PubMed ID: 27433943
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation.
    Akın L; Kurtoglu S; Yikilmaz A; Kendirci M; Elmalı F; Mazicioglu M
    Acta Paediatr; 2013 Mar; 102(3):e107-13. PubMed ID: 23190373
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
    Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
    Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
    Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
    Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
    Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD.
    Shabbirhussain BV; Singh S; Dixit VK; Verma A; Singh SK
    Diabetes Metab Syndr; 2022 Jul; 16(7):102560. PubMed ID: 35816948
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Metabolic-associated fatty liver disease in relation to site-specific and multiple-site subclinical atherosclerosis.
    Wang X; Zhang R; Man S; Lv J; Yu C; Yin J; Wang X; Deng Y; Wang B; Li L; Pang Y
    Liver Int; 2023 Aug; 43(8):1691-1698. PubMed ID: 37337780
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity.
    Koot BG; de Groot E; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; Jansen PL; Stoker J; Benninga MA
    Obesity (Silver Spring); 2015 Jun; 23(6):1239-43. PubMed ID: 25960049
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
    Ampuero J; Gallego-Durán R; Romero-Gómez M
    Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy.
    Caserta CA; Mele A; Surace P; Ferrigno L; Amante A; Messineo A; Vacalebre C; Amato F; Baldassarre D; Amato M; Marcucci F; Zuin M
    Ann Ist Super Sanita; 2017; 53(1):77-81. PubMed ID: 28361809
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease.
    Hanafy AS; Seleem WM; El-Kalla F; AbdAlkhalik Basha M; Abd-Elsalam S
    Diabetes Metab Syndr; 2019; 13(3):2272-2278. PubMed ID: 31235168
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Hypothetical Alcohol Consumption Interventions and Hepatic Steatosis: A Longitudinal Study in a Large Cohort].
    Zhang N; Zhang Y; Wei J; Xiang Y; Hu Y; Xiao X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):653-661. PubMed ID: 38948274
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Is treatment of fatty liver effective on reducing carotid intima media thickness; a cohort study.
    Ghaffarifar S; Khoshbaten M; Dordaei F; Zareh Nahandi M; Javad-Rashid R; Shahnazi T
    Gastroenterol Hepatol Bed Bench; 2018; 11(1):9-14. PubMed ID: 29564059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.